๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Spinal and Bulbar Muscular Atrophy

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site๐Ÿ“ Sioux Falls Sanford Health A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1) NCT07723248Phase 312 sites๐Ÿ“ Coral Springs๐Ÿ“ Jeffersonville๐Ÿ“ Holland ORIC Pharmaceuticals ยท Tests: Rinzimetostat, Darolutamide, Enzalutamide, Docetaxel A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer NCT07832292Phase 25 sites๐Ÿ“ Lafayette๐Ÿ“ Plymouth๐Ÿ“ Syracuse Janssen Research & Development, LLC ยท Tests: JNJ-101556143 A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer NCT06457919Phase 1, Phase 212 sites๐Ÿ“ New Haven๐Ÿ“ Basking Ridge๐Ÿ“ Middletown Memorial Sloan Kettering Cancer Center ยท Tests: Tinengotinib, abiraterone acetate with prednisone, Enzalutamide A Study of Real-World Characteristics, Treatment Patterns, and Outcomes Among mCRPC Patients Previously Treated With an Androgen Receptor Pathway Inhibitor, Taxane-Based Chemotherapy, and Lutetium-177 Vipivotide Tetraxetan NCT07677267n/a1 site๐Ÿ“ East Hanover Novartis Pharmaceuticals Study of ORIC-944 in Patients With Metastatic Prostate Cancer NCT05413421Phase 127 sites๐Ÿ“ Colorado Springs๐Ÿ“ Plantation๐Ÿ“ Arlington Heights ORIC Pharmaceuticals ยท Tests: ORIC-944, Abiraterone acetate (Zytigaยฎ) 250 mg or 500 mg tablets, Apalutamide (Erleadaโ„ข) 60 mg or 240 mg tablets, Darolโ€ฆ High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe) NCT07223385Phase 21 site๐Ÿ“ Los Angeles Cedars-Sinai Medical Center ยท Tests: Cardio-Oncology Referral, Notification to PCP/General Cardiologist A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer NCT07570979Phase 113 sites๐Ÿ“ Boston๐Ÿ“ Dallas๐Ÿ“ Melbourne Novartis Pharmaceuticals ยท Tests: INR731, Enzalutamide, Abiraterone, Androgen deprivation therapy (ADT) A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer NCT06099769Phase 212 sites๐Ÿ“ Birmingham๐Ÿ“ San Francisco๐Ÿ“ Chicago Memorial Sloan Kettering Cancer Center ยท Tests: Enzalutamide, Mifepristone, TPC Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA โ‰ฅ 0.2 ng/mL (EvoPAR-PR05) NCT07711002Phase 3210 sites๐Ÿ“ Hot Springs๐Ÿ“ Springdale๐Ÿ“ Beverly Hills AstraZeneca ยท Tests: Saruparib, Placebo, Enzalutamide, Darolutamide, Abiraterone Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer NCT07751133Phase 32 sites๐Ÿ“ Manchester๐Ÿ“ Sutton University College, London ยท Tests: Abiraterone, Apalutamide, Enzalutamide or Darolutamide (ARPI therapy) (per standard of care) therapy A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC NCT07226986Phase 1, Phase 225 sites๐Ÿ“ Los Angeles๐Ÿ“ Durham๐Ÿ“ El Paso Novartis Pharmaceuticals ยท Tests: AMO959, AAA617, Enzalutamide, Abiraterone Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer NCT06631521Phase 11 site๐Ÿ“ Orlando AdventHealth ยท Tests: Darolutamide, Relugolix, Radical Prostatectomy Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response NCT07142551Phase 21 site๐Ÿ“ Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ยท Tests: Testosterone cypionate, Luteinizing hormone-releasing hormone (LHRH) analogue, Darolutamide Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response NCT06592924Phase 3395 sites๐Ÿ“ Anchorage๐Ÿ“ Anchorage๐Ÿ“ Anchorage Canadian Cancer Trials Group ยท Tests: Abiraterone, Enzalutamide, Apalutamide, Darolutamide (BAY 1841788), Docetaxel Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer NCT04946370Phase 1, Phase 24 sites๐Ÿ“ Boston๐Ÿ“ Brooklyn๐Ÿ“ New York Weill Medical College of Cornell University ยท Tests: 225Ac-J591, Pembrolizumab, Androgen receptor inhibitor, 68Ga-PSMA-11 Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC NCT06855277Phase 3106 sites๐Ÿ“ Homewood๐Ÿ“ Tucson๐Ÿ“ Orange Novartis Pharmaceuticals ยท Tests: AAA817, ARPI, Standard of Care Study of Oral MRT-2359 With Apalutamide in Prostate Cancer NCT07745361Phase 214 sites๐Ÿ“ Los Angeles๐Ÿ“ Newport Beach๐Ÿ“ Colorado Springs Monte Rosa Therapeutics, Inc ยท Tests: Oral MRT-2359, Apalutamide A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide NCT06844383Phase 28 sites๐Ÿ“ Duarte๐Ÿ“ La Jolla๐Ÿ“ Boston Prostate Cancer Clinical Trials Consortium ยท Tests: Talazoparib with enzalutamide, Talazoparib Metastasis-directed Therapy for Oligorecurrent Prostate Cancer NCT05352178Phase 31 site๐Ÿ“ Leuven Universitaire Ziekenhuizen KU Leuven ยท Tests: Radiotherapy (SBRT) and/or surgery (metastasectomy), Androgen deprivation therapy, Androgen receptor targeted therapy Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA) NCT04944940n/a1 site๐Ÿ“ Bethesda National Institute of Neurological Disorders and Stroke (NIโ€ฆ Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC NCT07016399Phase 21 site๐Ÿ“ Nashville Vandana Abramson ยท Tests: Biospecimen Collection, Breast Biopsy Procedure, Carboplatin, Cyclophosphamide, Darolutamide Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma NCT06348264Phase 22 sites๐Ÿ“ Beijing๐Ÿ“ Beijing Peking University First Hospital ยท Tests: Rezvilutamide, Leuprolide Acetate TherApeutics in Early ProState Cancer (TAPS02) NCT05191680Phase 26 sites๐Ÿ“ Cambridge๐Ÿ“ Bristol๐Ÿ“ Bury St Edmunds Cambridge University Hospitals NHS Foundation Trust ยท Tests: Apalutamide Oral Tablet [Erleada], Placebo Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT) NCT05404139Phase 22 sites๐Ÿ“ Toronto๐Ÿ“ Toronto University Health Network, Toronto ยท Tests: Abiraterone, Standard of Care SBRT and ADT, Atorvastatin Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate Cancer NCT07260435Phase 326 sites๐Ÿ“ Alkmaar๐Ÿ“ Amersfoort๐Ÿ“ Amsterdam Nick Beije ยท Tests: ADT plus only 12 months of ARPI, ADT plus continued ARPI Clinical Trial of Mexiletine Hydrochloride for Spinal and Bulbar Muscular Atrophy NCT06862596Phase 2, Phase 35 sites๐Ÿ“ Bunkyล City๐Ÿ“ Chiba๐Ÿ“ Sapporo Masahisa Katsuno ยท Tests: Mexiletine hydrochloride, Placebo Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial NCT07650240Phase 21 site๐Ÿ“ Rochester Mayo Clinic ยท Tests: Abiraterone Acetate, Biospecimen Collection, Leuprolide Acetate, Lutetium Lu 177 Vipivotide Tetraxetan, Prednisone PET/CT Characterization of Treatment Resistance NCT05647564NA1 site๐Ÿ“ Madison University of Wisconsin, Madison ยท Tests: F-fluorodeoxyglucose positron emission tomography (FDG PET), prostate-specific membrane antigen positron emission tomogโ€ฆ An Observational Study to Learn More About How Medicines That Block Male Hormones Are Used in People With Prostate Cancer in Australia NCT07223372n/a1 site๐Ÿ“ Pymble Bayer
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy